Author

A. Chatziioannou

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Assay:bulk RNA-seq· 3 Approach:experimental assay· 3 Approach:statistical model· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2

Frequent Co-Authors

A. Obiedat· 2 shared A. Pandit· 2 shared B. Tirosh· 2 shared e. chevet· 2 shared J. Obacz· 2 shared J. Samal· 2 shared K. Voutetakis· 2 shared Q. Zheng· 2 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Obiedat

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Genomic characteristics and clinical significance of CD56+ Circulating Tumor Cells in Small Cell Lung Carcinoma

C. Ricordel, L. Chaillot, E.-I. Vlachavas, M. Logotheti, A. Jouannic, T. Desvallees, G. Lecuyer, M. Aubry, G. Kontogianni, C. Mastrokalou, F. Jouan, U. Jarry, R. Corre, Y. Le Guen, T. Guillaudeux, , R. Pedeux

This study isolates and analyzes CD56+ circulating tumor cells in SCLC, finding they have distinct genomic features and are associated with disease extension.

bioRxiv · Apr 30, 2022Cancer Biology

Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts

M. Berdiel, A. Maia, Z. Hristova, S. Borgoni, M. Vetter, S. Burmester, C. Becki, K. Abnaof, I. Binenbaum, D. Bethmann, A. Chatziioannou, M. Hasmann, C. Thomssen, E. Espinet, S. Wiemann

The paper identifies NRG1-expressing cancer-associated fibroblasts that promote fibrosis and migration through autocrine signaling, independent of HER3, and highlights HAS2 as a targetable molecule.

bioRxiv · Apr 6, 2020Cancer Biology

Novel IRE1-dependent proinflammatory signaling controls tumor infiltration by myeloid cells.

J. Obacz, J. Archambeau, P. J. Le Reste, R. Pineau, K. Barroso, E. Vlachavas, K. Voutetakis, T. Fainsod-Levi, A. Obiedat, Z. Granot, B. Tirosh, J. Samal, A. Pandit, J. Patterson, Q. Zheng, , e. chevet

This study identifies an IRE1-dependent proinflammatory signaling pathway in glioblastoma that promotes tumor invasion, angiogenesis, and myeloid cell infiltration.

bioRxiv · Jan 11, 2020Cancer Biology

Constitutive UPRER activation sustains tumor cell differentiation

D. Doultsinos, M. McMahon, K. Voutetakis, J. Obacz, R. Pineau, P.-J. Le Reste, A. Obiedat, J. Samal, J. B. Patterson, Q. Zheng, A. Samali, A. Pandit, B. Tirosh, A. Chatziioannou, E. Chevet, T. Avril

The paper shows that constitutive IRE1 activation maintains differentiation in glioblastoma cells by repressing stemness factors.

bioRxiv · Oct 22, 2019 · PreprintCancer Biology